Company intelligence / Profile preview

Preventor µTBC

Pfungstadt, Hessen, Germanypreventor.de ↗
Ownership
Private
Employees
~15
Development stage
Other
01

Overview

Preventor µTBC GmbH is a German biotechnology and drug safety company founded in 1998 by Prof. Dr. Paul Kerth. The company specializes in the development, production, and distribution of rapid and preventive diagnostics, theranostics, and formulation development, with a focus on ophthalmology, immunology, hematology, and cardiology. Key technologies include the Micro Tele BioChip (µTBC) and the Blood Liquid Separation Chip (BLISC), a capillary blood-plasma separation microchip based on physical separation. Preventor µTBC also provides contract research and manufacturing services, including anti-counterfeiting analysis, active ingredient design, bioequivalence testing (using its SuperSol 1000 system), and regulatory expertise. Additionally, the company manufactures and distributes organic formulations and premium animal health products, such as BeneFishial Pet, an anti-inflammatory omega-3 food supplement for cats and dogs.

Therapeutic areas
ImmunologyOphthalmologyCardiovascularRare DiseasesHematology
Modalities
Small moleculeBiologicBotanical extractHerbal medicinePeptidesRecombinant protein
Industry
Drug Discovery Services
02

Partnerships

Pivotal TherapeuticsHessen Life Sciences Chemie AGUniversity of Freiburg

Beyond the preview

Go deeper on Preventor µTBC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Preventor µTBC.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call